Increasingly more confident
Kromek is pioneering digital colour imaging for x- and gamma rays, using cadmium zinc telluride crystals. Key markets include medical imaging, homeland security and nuclear detection. Hot on the heels of winning up to $3.3m of home security contracts in late July with the US government, Kromek today said that it had secured two more significant orders. Both are within healthcare and together worth >$1m. The first for $700k with a new OEM to supply CZT detectors for nuclear medicine applications to be shipped over the next 18 months. Here the devices will generate sharper images in quicker timeframes and at lower radiation levels – thus enabling much improved patient outcomes. The second being a £340k repeat order from an existing BMD customer (Bone Mineral Densitometry) which will be delivered in FY19. We are encouraged by these developments – ie two major announcements in <1 month - and suspect it might be a reflection of management’s increasing confidence in meeting our estimates for this year and next. Better still, today’s news also reinforces the ongoing shift from CZT development work to selling commercial products, along with offering future upsell opportunities, bolstering the orderbook and enhancing revenue visibility (ED estimate for FY19 >2/3rds).Kromek Group is a developer of radiation detectors based on cadmium zinc telluride, providing detection and characterization capabilities within the medical imaging, nuclear detection and security screening markets. Co. designs, develops and produces x-ray and gamma-ray imaging and radiation detection products.
Equity Development enables companies to become better understood and supported by investors. Since our launch in 1996 we have consistently focused on helping our clients improve their communication and relationships with both existing and potential shareholders. Our clients have come from a wide variety of sectors and domiciles, are both private and quoted and range in size from micro-cap to $multi-billions. We offer free access to company research notes written by experienced analysts. These notes include detailed forecasts, financial models and a fair value. We host regular Private Investor Forums at which investors have the opportunity to hear company directors present, and to ask questions. These are free to attend. We broadcast live Webinars with company management that include active Q&A. We also make the recordings available online. We arrange face to face meetings between private investors and company management. We are active users of Twitter, commenting daily on company news, share price moves, Directors’ Dealings, Equity Development Research Notes & Events.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.